Wednesday, September 2, 2009

PPHM

Interim Phase II Data Presented at XIV World Congress of Neurological Surgery Supports Potential of Peregrine's Cotara(R) for Treatment of Brain Cancer.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)